Airway diseases
Poster session
Paediatric viral and bacterial lung infections
Clinical
Methods :
Pulmonary function testing, Cell and molecular biology, Epidemiology, General respiratory patient care, Public health, Physiology, Imaging
An urbanized metabolic and airway immune profile increases the risk of infections in early childhood
N. Brustad(Gentofte, Denmark)
COI
1
Environmental risk factors for respiratory infection and wheeze in early childhood: a multi-centre cohort study
T. Ruffles(hove, United Kingdom)
COI
2
A prospective study of community-acquired lower respiratory tract infections during the first year of premature newborns
A. Kassim(Kuala Lumpur (Wilayah Persekutuan), Malaysia)
COI
3
Genotypic diversity and immune dysregulation in children with HRA(rhinovirus) infections __PRESENT __PRESENT
A. Zafar(Hofuf, Saudi Arabia)
COI
4
Air pollutants exposure and risk of hospitalization due to RSV in Polish children
A. Badyda(Warszawa, Poland)
COI
5
Passive maternal anti-RSV immunization is influenced by the season of birth
M. Conti(Roma, Italy)
COI
6
Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection
S. Pischedda(Santiago de Compostela, Spain)
COI
7
Monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for severity in hospitalized children with RSV bronchiolitis
I. Golan-Tripto(Beer sheva, Israel)
COI
8
Midlands empyema in paediatrics: A UK multicentre retrospective case series review
N. Rowbotham(Derby, United Kingdom)
COI
9
Evaluation of pulmonary function tests and predictors in necrotizing pneumonia
Z. Onay(Istanbul, Turkey)
COI
10
Distinction Between Hemoptysis and Pseudohemoptysis; Cross-Sectional Retrospective Study
S. Can Oksay(İstanbul, Turkey)
COI
11
How do SARS-CoV-2 pandemic measures influence prevalence of respiratory viruses in healthy infants?
R. Steinberg(Bern, Switzerland)
COI
12
Spike specific salivary IgA2 is not induced or boosted by BNT162b2 vaccine in children
M. Conti(Roma, Italy)
COI
13
Exercise capacity is preserved in children six months after COVID-19 infection.
C. Ferrero(Nichelino (TO), Italy)
COI
14
Prospective evaluation of lung function in children with history of neonatal COVID-19 infection: preliminary data.
S. Nobile(Rome, Italy)
COI
15
Pulmonary evaluation in children with Long-COVID
P. Di Filippo(Chieti (CH), Italy)
COI
16
Late Breaking Abstract - A living network meta-analysis comparing modalities in the management of pediatric empyema
C. Fernández elviro(Lausanne, Switzerland)
COI
17
Late Breaking Abstract - Fibrinolytics use in children with pleural empyema
C. de Jong(Stettlen, Switzerland)
COI
18
. . .
